Delayed Treatment with Recombinant Human Tissue Factor Pathway Inhibitor Improves Survival in Rabbits with Gram‐Negative Peritonitis
Open Access
- 1 March 1998
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 177 (3) , 668-676
- https://doi.org/10.1086/514246
Abstract
To determine whether treatment with recombinant human tissue factor pathway inhibitor (TFPI), an inhibitor of the extrinsic coagulation pathway, canKeywords
This publication has 0 references indexed in Scilit: